Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine in Septic Shock
IRCT20100228003449N25Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of midodrine in sepsis and septic shock, sponsored by Tehran University of Medical Sciences. Started Sep 2019; status: completed.
02
Drugs
midodrine
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on IRCT20100228003449N25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100228003449N25.